There is increasing evidence for heterogeneity in oligodendrocyte populations, showing distinct transcriptional profiles, including MS mouse models with disease-associated (SERPINA3) signature of oligodendrocytes (25, 29–32). This evidence concerns the gene SERPINA3 and myeloid sarcoma.